Entering text into the input field will update the search result below

Pear Therapeutics expands program with Brightview on prescription digital therapeutics

Jan. 26, 2023 9:11 AM ETPear Therapeutics, Inc. (PEARQ) StockBy: Jonathan Block, SA News Editor1 Comment

Online healthcare app on smartphone screen.

tadamichi/iStock via Getty Images

  • Pear Therapeutics and BrightView Health have expanded a pilot program providing prescription digital therapeutics for substance use disorders.
  • The expansion means that Pear's (NASDAQ:PEAR) reSET and reSET-O therapeutics are now available to BrightView patients in Kentucky, Ohio, Delaware, Massachusetts, and Virginia.
  • ReSET is a monotherapy for patients 18 years of age or older with substance use disorder, while reSET-O is used in combination with buprenorphine for opioid use disorder.
  • Earlier in January, Pear (PEAR) expanded a partnership with Spero Health to provide the same two PDTs.

Recommended For You

About PEARQ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PEARQ--
Pear Therapeutics, Inc.